S1 Ep11: The Promise of Genetic Innovation & Cracking the Code of ALS

The Elixir Factor - A podcast by Eli Lilly and Company

There is great hope in the idea that a better understanding of gene mutations, RNA, and RNAi could lead to possible treatments and cures for some of the most difficult diseases, such as ALS. However, the path to finding a cure requires collaboration across academia, government, non-profits, the pharmaceutical industry and ongoing investments in innovation. No one understands this concept better than patient advocates. On our final episode of 2019, Joe talks to powerhouse couple, Brian Wallach and Sandra Abrevaya, about I AM ALS. Hear what factors inspired them build I AM ALS, a patient-centric movement, that is raising both awareness and funds for ongoing ALS research. Joe also talks to Lilly scientist, Andrew Adams about the process of RNA/RNAi interference and the development of therapies to correct the consequences of gene mutations. To learn more go to https://iamals.org/